期刊文献+

POEMS综合征的诊断和治疗 被引量:20

Diagnosis and therapy for POEMS syndrome
下载PDF
导出
摘要 POEMS综合征是一种罕见的浆细胞疾病,近年来在POEMS的诊断和治疗方面都取得了很大进展。本文将重点阐述POEMS综合征的诊断标准以及早期诊断的要点。在治疗方面,自体造血干细胞移植由于其较好的疗效已经成为年轻POEMS综合征患者的一线治疗。马法兰联合地塞米松也有着较高的缓解率和很好的安全性,可以作为老年或其他不适合移植患者的治疗选择。新药例如来那度胺等给POEMS综合征患者提供了更多的治疗选择。 POEMS syndrome is a rare clonal plasma cell disease characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes. Significant advances have been made in the diagnosis and treatment of POEMS syndrome over the last decade. In this study, we reviewed the diagnostic criteria and characteristic features of POEMS syndrome. We also focused on the role of the characteristic features of POEMS syndrome in early diagnosis. Autologous peripheral blood stem cell transplantation has become the first-line treatment for younger patients with normal organ function because it has resulted in a high response rate and durable remission. Melphalan and dexamethasone is an effective and well-tolerated treatment for older patients and those with organ dysfunction. Patients with poor performance status or renal function can benefit from novel agents that can also improve transplantation eligibility.
作者 周道斌 李剑
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2014年第13期831-835,共5页 Chinese Journal of Clinical Oncology
关键词 POEMS综合征 自体外周血干细胞移植 马法兰 来那度胺 POEMS syndrome, autologous peripheral blood stem cell transplantation, melphalan, lenalidomide
  • 相关文献

参考文献23

  • 1Li J, Zhou DB, Huang Z, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China[K]. Ann Hematol, 2011, 90(7):819-826.
  • 2Abe D, Nakaseko C, Takeuchi M, et al. Restrictive usage of mono- clonal immunoglobulin light chain germline in POEMS syndrome [J]. Blood, 2008, 112(3):836-839.
  • 3Watanabe O, Arimura K, Kitajima I, et al. Greatly raised vascula endothelial growth factor (VEGF) in POEMS syndrome[K]. Lancet 1996, 347(9002):702.
  • 4D'Souza A, Hayman SR, Buadi F, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and foUow-up of patients with POEMS syndrome[J]. Blood, 2011, 118(17):4663--4665.
  • 5Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymhoid tissues: Osteoslcerotic my- eloma (POEMS syndrome)[M]. Lyon: IRAC, 2008:212-213.
  • 6Dispenzieri A, Kyle RA, Lacy MO et al. POEMS syndrome: defini- tions and long-term outcome[J].Blood, 2003, 101(7):2496-2506.
  • 7Dispenzieri A. POEMS syndrome[K]. Blood Rev, 2007, 21(6):285-299.
  • 8Dispenzieri A. POEMS syndrome: 2011 update on diagn risk-stratification, and management[K]. AmJ Hematol, 2011, 861 591-601.
  • 9Dispenzieri A. Ushering in a new ear for POEMS[J]. Blood, 2011, 117 (24) :6405-6406.
  • 10Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involve- ment and treatment response in immunoglobulin light chain amyloi- dosis (AL): a consensus opinion from the 10th International Sympo- sium on Amyloid and Amyloidosis[J]. AmJ Hematol, 2005, 79(4):319-328.

同被引文献118

引证文献20

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部